TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 226 filers reported holding TG THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $765,776 | -57.5% | 91,600 | +26.2% | 0.12% | -55.4% |
Q2 2023 | $1,803,384 | +65.2% | 72,600 | 0.0% | 0.26% | +53.8% |
Q1 2023 | $1,091,904 | +27.1% | 72,600 | 0.0% | 0.17% | +21.6% |
Q4 2022 | $858,858 | +99.7% | 72,600 | 0.0% | 0.14% | +87.8% |
Q3 2022 | $430,000 | +273.9% | 72,600 | +168.9% | 0.07% | +289.5% |
Q2 2022 | $115,000 | -55.3% | 27,000 | 0.0% | 0.02% | -45.7% |
Q1 2022 | $257,000 | -49.9% | 27,000 | 0.0% | 0.04% | -46.2% |
Q4 2021 | $513,000 | -42.9% | 27,000 | 0.0% | 0.06% | -46.7% |
Q3 2021 | $899,000 | -14.1% | 27,000 | 0.0% | 0.12% | -12.2% |
Q2 2021 | $1,047,000 | -19.5% | 27,000 | 0.0% | 0.14% | -24.9% |
Q1 2021 | $1,301,000 | -7.4% | 27,000 | 0.0% | 0.18% | -14.7% |
Q4 2020 | $1,405,000 | +94.3% | 27,000 | 0.0% | 0.22% | +66.9% |
Q3 2020 | $723,000 | +37.5% | 27,000 | 0.0% | 0.13% | +31.3% |
Q2 2020 | $526,000 | +97.7% | 27,000 | 0.0% | 0.10% | +62.3% |
Q1 2020 | $266,000 | -11.3% | 27,000 | 0.0% | 0.06% | +19.6% |
Q4 2019 | $300,000 | +97.4% | 27,000 | 0.0% | 0.05% | +82.1% |
Q3 2019 | $152,000 | – | 27,000 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
M28 Capital Management LP | 726,200 | $3,086,000 | 3.46% |
Paradigm Biocapital Advisors LP | 1,964,709 | $8,350,000 | 1.66% |
683 Capital Management, LLC | 3,300,000 | $14,025,000 | 0.99% |
MAVERICK CAPITAL LTD | 6,747,549 | $28,677,000 | 0.71% |
Antara Capital LP | 1,500,000 | $6,375,000 | 0.27% |
Parkwood LLC | 47,168 | $1,375,000 | 0.24% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,677,500 | $11,379,000 | 0.24% |
PURA VIDA INVESTMENTS, LLC | 950,813 | $4,041,000 | 0.24% |
OCCUDO QUANTITATIVE STRATEGIES LP | 567,576 | $2,412,000 | 0.20% |
Antara Capital LP | 900,000 | $3,825,000 | 0.16% |